
Overview
Shani Gunning-Carter, MD, specializes in hematology oncology and is certified in hematology, medical oncology and internal medicine by the American Board of Internal Medicine. She practices at UPMC Hillman Cancer Center in Harrisburg and is affiliated with UPMC Hanover, UPMC Carlisle, UPMC Lititz, UPMC Harrisburg, UPMC Community Osteopathic, UPMC Memorial and UPMC West Shore. She completed her medical school at University of the West Indies at Kingston, fellowship and residency programs at SUNY Downstate Medical Center, and fellowship program at UPMC.
Dr. Carter is highly rated in 6 conditions, according to our data. Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Non-Muscle Invasive Bladder Cancer, and Muscle Invasive Bladder Cancer.
Graduate Institution
Residency
Specialties
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1703 Innovation Drive, Suite 2001, York, PA 17408
Sidney Kimmel Comprehensive Cancer Center
Dr. Ivana Gojo is a Hematologist/Oncologist in Baltimore. Her clinical focus is on diagnosis and management of patients with acute leukemias (AML, ALL) and other myeloid malignancies (MDS, MPNs, CML), with emphasis on the development of novel therapeutic approaches for these diseases. She is nationally and internationally recognized expert in clinical translation of novel therapeutics for acute leukemias and principal investigator on multiple multi-center investigator-initiated studies. Dr. Gojo joined the Johns Hopkins faculty in 2012 as the Co-Director of Leukemia Drug Development Program. She has served on the National Cancer Institute (NCI) Investigational Drug Steering Committee since 2014. Dr. Gojo received a Service Star Award from Johns Hopkins Medicine Service Excellence in 2018 for her exemplary care of leukemia patients. Dr. Gojo contributed to the clinical translational and drug development effort of multiple novel agents targeting pathogenic pathways in patients with acute leukemia. Her research efforts are now concentrated on the development and integration of novel immunotherapies into therapeutic armamentarium for patients with acute leukemia. She mentors basic and clinical research fellows and junior faculty on the development and design of novel clinical trials and mechanistic laboratory studies associated with these trials. She served as a leukemia team leader on the National Institute of Health (NIH)/NCI N01 grant (Phase II consortium) (2009-2011), and is co-principal investigator (PI) on the Experimental Therapeutics (ET)-Clinical Trial Network (CTN) UM1 grant supporting early clinical trials. Dr. Gojo has served on the National Comprehensive Cancer Network guideline panel for AML since 2019, Myeloid Growth Factor guideline panel since 2015 and previously served on the MPNs guideline panel (2016-2019). She has extensive experience in the regulatory aspects of drug development and served as the Chair (2015-2016) and Co-Chair (2014-2015) of the Cancer Research Review Committee at Sidney Kimmel Comprehensive Cancer Center (SKCCC) at Johns Hopkins, and serves as a member of the SKCCC Biostatistics Core Advisory Committee and SKCCC Clinical Research Office Coordinating Center Oversight Committee. Dr. Gojo is highly rated in 16 conditions, according to our data. Her top areas of expertise are Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant.
Cancer Care Associates Of York
Chanh Huynh is a Hematologist Oncology specialist and an Oncologist in York, Pennsylvania. Dr. Huynh has been practicing medicine for over 22 years is highly rated in 74 conditions, according to our data. His top areas of expertise are Large-Cell Immunoblastic Lymphoma, Colorectal Cancer, Lynch Syndrome, Familial Colorectal Cancer, and Bone Marrow Aspiration.
Cancer Care Associates Of York
Dan Sotirescu is a Hematologist Oncology specialist and an Oncologist in York, Pennsylvania. Dr. Sotirescu has been practicing medicine for over 40 years is highly rated in 45 conditions, according to our data. His top areas of expertise are Colorectal Cancer, Severe Congenital Neutropenia, Familial Colorectal Cancer, Lung Cancer, and Bone Marrow Aspiration.
Frequently Asked Questions about Dr. Shani N. Carter
How do I make an appointment with Dr. Shani N. Carter?
You can book an appointment with Dr. Shani N. Carter by calling their office at 717-801-0765. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Shani N. Carter a top-rated expert for Paget Disease of the Breast?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Shani N. Carter is classified as an Advanced expert for Paget Disease of the Breast, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Shani N. Carter specialize in?
While Dr. Shani N. Carter is a Hematology Oncology, they have specific expertise in Paget Disease of the Breast, Breast Cancer, and Non-Muscle Invasive Bladder Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology Oncology.
Does Dr. Shani N. Carter accept my insurance?
Dr. Shani N. Carter accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 717-801-0765 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Bladder CancerDr. Carter isAdvanced. Learn about Bladder Cancer.
- Breast CancerDr. Carter isAdvanced. Learn about Breast Cancer.
- Muscle Invasive Bladder CancerDr. Carter isAdvanced. Learn about Muscle Invasive Bladder Cancer.
- Non-Muscle Invasive Bladder Cancer
- Paget Disease of the BreastDr. Carter isAdvanced. Learn about Paget Disease of the Breast.
- Urothelial CancerDr. Carter isAdvanced. Learn about Urothelial Cancer.
- Experienced
- Adult Immune ThrombocytopeniaDr. Carter isExperienced. Learn about Adult Immune Thrombocytopenia.
- AgranulocytosisDr. Carter isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Carter isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- AnemiaDr. Carter isExperienced. Learn about Anemia.
- AngiosarcomaDr. Carter isExperienced. Learn about Angiosarcoma.
- Childhood Iron Deficiency AnemiaDr. Carter isExperienced. Learn about Childhood Iron Deficiency Anemia.



